84 related articles for article (PubMed ID: 24815508)
41. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells.
Marecki JC; McCord JM
Arch Biochem Biophys; 2002 Jun; 402(2):227-34. PubMed ID: 12051667
[TBL] [Abstract][Full Text] [Related]
42. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
Le TV; Suh JH; Kim N; Park HJ
Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
[TBL] [Abstract][Full Text] [Related]
43. Differential role of poly(ADP-ribose) polymerase-1in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro.
Meli E; Pangallo M; Picca R; Baronti R; Moroni F; Pellegrini-Giampietro DE
Mol Cell Neurosci; 2004 Jan; 25(1):172-80. PubMed ID: 14962750
[TBL] [Abstract][Full Text] [Related]
44. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
45. 5-Aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats.
Di Paola R; Mazzon E; Muià C; Terrana D; Greco S; Britti D; Santori D; Oteri G; Cordasco G; Cuzzocrea S
J Clin Periodontol; 2007 Feb; 34(2):95-102. PubMed ID: 17309584
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP).
Watson CY; Whish WJ; Threadgill MD
Bioorg Med Chem; 1998 Jun; 6(6):721-34. PubMed ID: 9681138
[TBL] [Abstract][Full Text] [Related]
47. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
48. AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
Liu M; Li Z; Chen GW; Li ZM; Wang LP; Ye JT; Luo HB; Liu PQ
Mol Cell Endocrinol; 2014 Jul; 392(1-2):14-22. PubMed ID: 24859603
[TBL] [Abstract][Full Text] [Related]
49. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.
Ahmad SF; Zoheir KM; Ansari MA; Korashy HM; Bakheet SA; Ashour AE; Al-Shabanah OA; Al-harbi MM; Attia SM
Mol Immunol; 2015 Feb; 63(2):394-405. PubMed ID: 25304310
[TBL] [Abstract][Full Text] [Related]
50. Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase.
Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Kerrigan F; Loh VM; Martin NM; Menear KA; Smith GC
Bioorg Med Chem Lett; 2006 Feb; 16(4):1040-4. PubMed ID: 16290932
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitors.
Tao M; Park CH; Bihovsky R; Wells GJ; Husten J; Ator MA; Hudkins RL
Bioorg Med Chem Lett; 2006 Feb; 16(4):938-42. PubMed ID: 16290935
[TBL] [Abstract][Full Text] [Related]
52. Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase.
Loh VM; Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Eversley PJ; Gomez S; Hoare J; Kerrigan F; Matthews IT; Menear KA; Martin NM; Newton RF; Paul J; Smith GC; Vile J; Whittle AJ
Bioorg Med Chem Lett; 2005 May; 15(9):2235-8. PubMed ID: 15837300
[TBL] [Abstract][Full Text] [Related]
53. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling.
Ishida J; Yamamoto H; Kido Y; Kamijo K; Murano K; Miyake H; Ohkubo M; Kinoshita T; Warizaya M; Iwashita A; Mihara K; Matsuoka N; Hattori K
Bioorg Med Chem; 2006 Mar; 14(5):1378-90. PubMed ID: 16288880
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography.
Zhou D; Chu W; Xu J; Jones LA; Peng X; Li S; Chen DL; Mach RH
Bioorg Med Chem; 2014 Mar; 22(5):1700-7. PubMed ID: 24503274
[TBL] [Abstract][Full Text] [Related]
55. Selective inhibition of PARP10 using a chemical genetics strategy.
Morgan RK; Carter-O'Connell I; Cohen MS
Bioorg Med Chem Lett; 2015 Nov; 25(21):4770-4773. PubMed ID: 26231158
[TBL] [Abstract][Full Text] [Related]
56. Novel poly(ADP-ribose) polymerase-1 inhibitors.
Dunn D; Husten J; Ator MA; Chatterjee S
Bioorg Med Chem Lett; 2007 Jan; 17(2):542-5. PubMed ID: 17074482
[TBL] [Abstract][Full Text] [Related]
57. Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors.
Zhao H; Ji M; Cui G; Zhou J; Lai F; Chen X; Xu B
Bioorg Med Chem; 2017 Aug; 25(15):4045-4054. PubMed ID: 28622906
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and biological evaluation of isoquinolin-1(2
Yao H; Wang Y; Jiangwen M; Peng Y; Wang Z
Pharmazie; 2021 Apr; 76(4):132-137. PubMed ID: 33849696
[TBL] [Abstract][Full Text] [Related]
59. The solid phase synthesis of tetrahydroisoquinolines having cdc25B inhibitory activity.
Fritzen EL; Brightwell AS; Erickson LA; Romero DL
Bioorg Med Chem Lett; 2000 Apr; 10(7):649-52. PubMed ID: 10762045
[TBL] [Abstract][Full Text] [Related]
60. N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.
Wannamaker MW; Waid PP; Van Sickle WA; McCarthy JR; Wilson PK; Schatzman GL; Moore WR
J Med Chem; 1992 Sep; 35(19):3581-3. PubMed ID: 1404239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
